Skip to content
Review

Bench to Bedside: Insights from Large Animal Models and Emerging Clinical Trials of Endogenous Cardiac Regeneration and Repair

Jul 2026 · Journal of Cardiovascular Translational Research · Vol 19 · 0 citations · 150 references
Medicine

TL;DR

This review summarizes a range of intervention strategies designed to wake up cardiac regeneration and promote myocardial repair in the setting of residual following myocardial injury, and discusses the translational progress of these strategies.

View source

Similar papers

Review Open access Sep 2026

Human iPSC models of myocardial infarction: From injury to repair and therapeutic discovery.

Myocardial infarction (MI) remains a leading cause of death worldwide, and therapies that limit injury, promote repair, and restore cardiac function remain limited. Human induced pluripotent stem cells (hiPSCs) provide a renewable source of patient-specific cardiac cells and have enabled the development of increasingly...

Benjamin B. Johnson, C. Mummery, Richard P. Davis · 0 citations
Review Open access Aug 2026

Stem Cell-Derived Cardiac and Conduction System Cells for Heart Regeneration and Repair: Current Progress and Future Directions.

This review evaluates recent developments in hiPSC technology, beginning with the generation of patient-specific models of inherited arrhythmias and cardiomyopathies, and examines progress in directing hiPSCs into specialized lineages, including cardiomyocytes, pacemaker cells, and Purkinje fibers.

Berra Koskulu, Tabish Ali, Ilkin Tetik-Altintop et al. · 0 citations
Review Aug 2026

Clinical potential and challenges of extracellular vesicles in myocardial infarction therapy.

This review systematically analyzes the key issues facing EV-based therapeutic strategies in their progression from experimental research to clinical application, providing a practical theoretical framework for EV-based myocardial repair therapies and clarifying the prospects for EVs in the treatment of MI.

Kaiyi Zhu, Jing Bai, Liang-Fu Xu et al. · 0 citations
Review Sep 2026

CAR-based immunotherapy for cardiac fibrosis: a new therapeutic frontier.

Cardiac fibrosis is a central pathological hallmark of diverse cardiovascular disorders, driving myocardial stiffening, ventricular dysfunction, and the progression of heart failure. Following cardiac injury, resident quiescent fibroblasts activate into pro‑fibrotic myofibroblasts, which overproduce extracellular matri...

Na Zhang, Xiao-Ming Feng, Wen-Chong Zou · 0 citations
Review Open access Sep 2026

Harnessing biomaterial-based immunomodulation for cardiac repair and regeneration

Ischemic heart disease is the leading cause of global morbidity and mortality. The immune system plays a pivotal role in the physiological and pathological processes within the cardiovascular system. The dysregulated inflammatory microenvironment in the heart can severely prevent infarcted cardiac repair by matrix degr...

Muhammad Rafique, Muhammad Umer Khan Niazi, Onaza Ali et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.